What this study is
Simplified from ClinicalTrials.govStudying outcomes and care of adults having transcatheter aortic valve replacement (TAVR, a procedure that replaces a diseased heart valve through a catheter) to help hospitals improve quality and safety, in people 18 and older whose hospitals submit their data to a national heart registry.
Read the original summary from ClinicalTrials.gov
The STS/ACC TVT Registry™ (TVT Registry), created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology Foundation (ACCF), is a benchmarking tool designed to assess the prevalence, demographics, management, and outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) procedure. Patient-level data will be submitted by participating hospitals to the TVT Registry via the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The primary aims of the TVT Registry, are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing TAVR procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the TVT Registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost effectiveness research, and as a scalable data infrastructure for pre and post market studies.
What's being tested
- Transcatheter Aortic Valve Replacement
Intervention · PROCEDURE
Procedure: Transcatheter Aortic Valve Replacement • Minimal invasive implantation of a biological prothesis in Aortic Position
Study details
- Official title
- STS/ACC TVT Registry™
- Sponsor
- American College of Cardiology
- Conditions
- Aortic Valve Stenosis
- Enrolling
- 50,000 people
- Starts
- 2026-09
- Est. completion
- 2036-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients 18 years or over on arrival at the facility undergoing transcatheter aortic valve replacement.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openAmerican College of Cardiology / National Cardiovascular Data Registry
Washington D.C., District of Columbia, United States
- NCDR Product Support · Contact1-800-257-4737ncdr@acc.org
Recruiting
Study team
Sponsor
American College of Cardiology
Study ID AmericanCC
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.